HANNA: A National, Prospective, Non-Interventional Study of Nivolumab (Nivo) in Patients (pts) with Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing On or After Platinum-Based Therapy

Abstract

Abstract is not available.